0 Commentaires
0 Parts
149 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
- Blogs
- Offres
- Emplois
- Connectez-vous pour aimer, partager et commenter!
- Luliconazole Cream Market to Reach USD 683 Million by 2034 | CAGR 5.8%According to a newly published market research report by 24LifeSciences, global luliconazole cream market was valued at USD 427 million in 2025 and is projected to reach USD 683 million by 2034, growing at a compound annual growth rate (CAGR) of 5.8% during the forecast period 20262034. Luliconazole cream is a broad-spectrum antifungal medication belonging to the imidazole class, clinically...0 Commentaires 0 Parts 44 Vue 0 Aperçu
- Pharmaceutical Industry Shifts Toward High-Potency APIs, Boosting Global Market GrowthModern medicine increasingly relies on powerful therapies that work at extremely small doses. Many breakthrough drugs for cancer, hormonal disorders, and targeted therapies depend on compounds that are highly potent yet precisely controlled. These substances are known as High Potency Active Pharmaceutical Ingredients (HPAPIs). The HP (High Potency) Active Pharmaceutical...0 Commentaires 0 Parts 149 Vue 0 Aperçu
- Pyridine and Pyridine Derivatives Market Industry Analysis Highlighting Chang Chun Petrochemical, Lonza Group and Resonance Specialties Forecast to 2031Pyridine is a nitrogen-containing heterocyclic compound with a structure comparable to benzene, where one carbon atom is replaced by nitrogen. It is widely used as a solvent and as an intermediate in the chemical industry. Thanks to its reactivity and basic nature, pyridine is involved in numerous chemical reactions used in industrial production. Pyridine derivatives are substances derived from...0 Commentaires 0 Parts 173 Vue 0 Aperçu
- RdRp Inhibitor Market to Reach USD 521.68 Million by 2028 | CAGR 8.2%According to a newly published market research report by 24LifeSciences, global RdRp inhibitor market was valued at USD 352.14 million in 2023 and is projected to reach USD 521.68 million by 2028, growing at a compound annual growth rate (CAGR) of 8.2% during the forecast period 2024-2028. RNA-dependent RNA polymerase (RdRp) inhibitors represent a critical antiviral therapy class that prevents...0 Commentaires 0 Parts 43 Vue 0 Aperçu